These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC). Likwela JL; D'Alessandro U; Lokwa BL; Meuris S; Dramaix MW Trop Med Int Health; 2012 Mar; 17(3):322-9. PubMed ID: 22212628 [TBL] [Abstract][Full Text] [Related]
6. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. Kayentao K; Kodio M; Newman RD; Maiga H; Doumtabe D; Ongoiba A; Coulibaly D; Keita AS; Maiga B; Mungai M; Parise ME; Doumbo O J Infect Dis; 2005 Jan; 191(1):109-16. PubMed ID: 15593011 [TBL] [Abstract][Full Text] [Related]
7. Antimalarials during pregnancy: a cost-effectiveness analysis. Schultz LJ; Steketee RW; Chitsulo L; Wirima JJ Bull World Health Organ; 1995; 73(2):207-14. PubMed ID: 7743592 [TBL] [Abstract][Full Text] [Related]
8. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069 [TBL] [Abstract][Full Text] [Related]
9. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. Kayentao K; Garner P; van Eijk AM; Naidoo I; Roper C; Mulokozi A; MacArthur JR; Luntamo M; Ashorn P; Doumbo OK; ter Kuile FO JAMA; 2013 Feb; 309(6):594-604. PubMed ID: 23403684 [TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443 [TBL] [Abstract][Full Text] [Related]
11. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120 [TBL] [Abstract][Full Text] [Related]
12. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878 [TBL] [Abstract][Full Text] [Related]
13. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial. Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of two-dose Igboeli NU; Adibe MO; Ukwe CV; Aguwa CN J Vector Borne Dis; 2018; 55(3):197-202. PubMed ID: 30618445 [TBL] [Abstract][Full Text] [Related]
15. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso. Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U Malar J; 2008 Sep; 7():180. PubMed ID: 18801158 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR Malar J; 2015 Feb; 14():69. PubMed ID: 25890159 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania. Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022 [TBL] [Abstract][Full Text] [Related]
18. Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial. Lingani M; Zango SH; Valéa I; Samadoulougou S; Somé G; Sanou M; Kaboré B; Rouamba T; Sorgho H; Tahita MC; Derra K; Dramaix M; Tinto H; Donnen P; Robert A Malar J; 2023 Mar; 22(1):101. PubMed ID: 36932435 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300 [TBL] [Abstract][Full Text] [Related]
20. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Peters PJ; Thigpen MC; Parise ME; Newman RD Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]